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Chronic Total Occlusions
The Power of Negative Thinking*John A. Bittl, MDI mpasses are common in everyday life. Whenthey occur in coronary arteries as chronic totalocclusions (CTOs), they may be difﬁcult to
treat. Successful treatment of CTOs sometimes re-
quires a nonconformist approach based on “negative
thinking,” which is described in philosophical circles
as the mindset that “negates” the possibility of failure
and replaces it with the potentiality of success (1).SEE PAGE 245To understand how negative thinking produces
positive results, I reviewed a report published in this
issue of JACC: Cardiovascular Interventions that
describes the use of percutaneous coronary inter-
vention for chronic total occlusions (CTO PCI) (2).
Brilakis and colleagues accessed the NCDR (National
Cardiovascular Data Registry) and found that CTO
PCI represented 22,365 of 594,510 procedures (3.8%)
of the total PCI volume for stable coronary artery
disease between 2009 and 2013. The investigators
observed that patients undergoing CTO PCI continue
to have lower procedural success rates than those
undergoing non-CTO PCI procedures (59% vs. 96%,
p < 0.001) and have twice the rate of major adverse
cardiac events (1.6% vs. 0.8%, p < 0.001). Although
the overall results are a sobering reminder that CTO
PCI remains a relatively low-yield undertaking, the
report makes several positive observations that
could improve clinical outcomes.*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
From the Munroe Regional Medical Center, Ocala, Florida. Dr. Bittl has
reported that he has no relationships relevant to the contents of this
paper to disclose.SURVIVAL
The current study adds to the emerging data to sug-
gest that successful CTO PCI improves survival.
Revascularization may enhance survival if there are
improvements in left ventricular function, a reduced
risk of arrhythmia, or better tolerance of future acute
coronary events (2–4).
In a systematic review of 13 studies of 7,288 pa-
tients, Joyal et al. (4) observed that successful
CTO PCI was associated with a lower risk of death
than failed CTO PCI (odds ratio [OR]: 0.56, 95%
conﬁdence interval [CI]: 0.43 to 0.72). In another
analysis involving the UK Central Cardiac Audit
Database for all CTO PCI cases performed in England
and Wales between 2005 and 2009, George et al. (3)
reported that successful CTO PCI of any target vessel
was associated with an overall 28% reduction in
mortality, as compared with failed CTO PCI. Of note,
the survival advantage of successful CTO PCI did not
depend on the location of the successfully recanal-
ized vessel but was observed to be similar for the
left anterior descending coronary artery (hazard ra-
tio [HR]: 0.69, 95% CI: 0.49 to 0.97), the left
circumﬂex (HR: 0.56, 95% CI: 0.38 to 0.82), and
the right coronary artery (RCA) (HR: 0.73, 95% CI:
0.57 to 0.95). The ﬁnding of improved survival
after successful CTO PCI of the left anterior
descending coronary artery might be supported by
the surgical literature (5), but the ﬁnding of im-
proved survival after opening the left circumﬂex or
RCA is puzzling.
The current report (2) puts the survival results
into clearer perspective by ﬁrst clarifying that suc-
cessful CTO PCI resulted in lower in-hospital mor-
tality rates than did failed CTO PCI (0.0% vs. 1.1%,
p < 0.001). Additional observations suggest that the
mortality differences after discharge were caused in
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255part by confounding. Patients with successful CTO
PCI were younger than those with failed CTO PCI
and had lower rates of prior myocardial infarction
(MI), diabetes, or prior stroke or coronary artery
bypass graft (CABG) surgery (2). These observations
suggest that patients with successful procedures
were healthier at baseline than the patients who
then “took a hit” from a failed CTO PCI. Not meant
to be a criticism of a ﬁne observational study, and as
encouraging as the ﬁndings for successful CTO PCI
are, the current analysis and the other observational
studies have been unable to deﬁnitively determine
whether long-term survival is attributable to the
decision to intervene, the outcome of CTO PCI itself,
or both.
No randomized study comparing CTO PCI with
medical treatment alone has been reported. The
EXPLORE (Evaluating Xience V and Left Ventricular
Function in Percutaneous Coronary Intervention
on Occlusions after ST-elevation Myocardial Infarc-
tion) trial (6) is a randomized, prospective, mul-
ticenter, 2-arm trial with blinded evaluation of
endpoints that is actively enrolling 300 patients
after primary PCI for ST-segment elevation MI with
a CTO in a noninfarct artery. Patients are random-
ized to either CTO PCI or medical treatment within
7 days after MI. Endpoints include left ventricular
function at 4 months and clinical outcomes at
5 years.
SYMPTOM RELIEF
Survival is not the only important outcome, and we
must not hold CTO PCI to a higher standard than
revascularization for other indications. Relief of
angina is another important goal of CTO PCI. The cur-
rent study (2) was unable to test whether CTO PCI
relieved symptoms in the 66% of patients with angina
before treatment or in the remaining patients without
angina. In 6 studies that reported anginal status (4),
successful CTO PCI was associated with a signiﬁcant
reduction in angina (OR: 0.45, 95% CI: 0.30 to 0.67).
Successful CTO PCI has also been associated with a
lower need for urgent (2) or elective (4) CABG than
failed CTO PCI.
NEGATING FAILURE
The current report (2) identiﬁed several baseline
characteristics associated with CTO PCI failure such
as older age, prior MI, prior CABG, history of cardiac
arrest, and target lesion in the RCA. Other studies
suggested that lesion length, calciﬁcation, blunt
stump, and a previously failed lesion were predictorsof failure; and calciﬁcation, tortuosity, blunt stump,
occlusion length >20 mm, and previously failed CTO
PCI were predictors of crossing failure (7). Higher
complexity also predicted longer procedures and
increased consumption of resources (7). This is
important, because the costs associated with CTO PCI
may appear unattractive to administrators. An
average CTO PCI case requires 9 guidewires, and
many cases incur extra costs for adjunctive imaging,
use of multiple stents, and additional vascular access
sites.
TEACHABLE SKILLS
The authors of the current study have made a critical
observation to make CTO PCI more efﬁcient and
successful. They observed that a larger annual vol-
ume of CTO PCI procedures per operator was associ-
ated with superior outcomes (2). Although only 8
operators performed 50 or more CTO PCI procedures
per year, the busier operators had higher procedural
success rates and lower complication rates than the
less experienced operators.
Experienced operators recognize that side
branches adjacent to CTO bifurcations are less likely
to occlude after a retrograde than after an antero-
grade approach. They also recognize that subintimal
passage probably occurs more commonly in CTO PCI
than had been realized. Fortunately, it seems unlikely
that a blunt device like a knuckled wire will exit the
adventitial space.
The skills required for successful CTO PCI are
teachable. Some authorities suggest that each center
should identify 1 or 2 “super-specialists” to acquire
expertise to perform CTO PCI (8). Regular meetings
and proctoring are important components of suc-
cessful CTO PCI programs. The acquisition of
specialized skills is essential for wiring of collaterals,
retrograde tracking, use of microcatheters and re-
entry systems, limiting contrast use, and setting
controls to reduce radiation exposure. Familiarity
with advanced techniques leads to improved
outcomes.
CONCLUSIONS
After successful CTO PCI, patients have less angina
and may have gained a survival advantage. Because
CTO PCI is challenging, achieving success often re-
quires inventive approaches. In order to transcend
the natural limitations of CTOs, interventional cardi-
ologists might consider the philosophical tool of
“negative thinking” (1) to replace 1-dimensional
techniques with multidimensional strategies,
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256augment the antegrade route with retrograde ap-
proaches, supplement a narrow selection of devices
with a broad assortment of new wires and micro-
catheters, and so transform CTO PCI failures into
clinical successes.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
John A. Bittl, Munroe Regional Medical Center, 1221
SE 5th Street, Ocala, Florida 34471. E-mail: jabittl@
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